KDM1A and central nervous system cancer: In glioma cells, inhibition of LSD1 reduces signaling controlled by the stemness-associated gene MYC, which is regulated by super-enhancers [20]; indeed, expression of MYC itself is downregulated following LSD1 inactivation [21].